Improved Prognostic Staging in Endometrial Cancer: Clinical Impact of Aggressive Subtypes in a Multicenter Cohort
Medical Sciences · 22.07.2026 · 14 (3) · 414
DOI: 10.3390/medsci14030414 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Medical Sciences, online erschienen am 22.07.2026. Verfasst von Tatiana Cuesta-Guardiola und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University Hospital of León, 24008 León, Spain. Hauptthemen laut MEDLINE: Endometrial Neoplasms. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Assessment of the impact on survival of endometrial carcinoma according to the 2009 FIGO (International Federation of Gynecology and Obstetrics) classification and the new FIGO 2023 classification highlighting the worse prognosis of the aggressive subtypes.
Methods
This multicenter retrospective study included 1181 patients with endometrial cancer. Comprehensive clinical, pathological and treatment-related variables were collected. Primary outcomes included overall survival assessed through five-year follow-ups. Statistical analysis included comparative tests, Kaplan–Meier survival estimation, Cox proportional hazards models and ROC curves analysis to review prognostic accuracy.
Results
Aggressive endometrial carcinoma (n = 353) showed significant worse overall survival compared with non-aggressive cases (35.7 versus 60 months). A novel classification based on FIGO 2023 was developed, integrating histological aggressiveness into a different stage and combining early non-aggressive stages in only one stage. While FIGO 2009 and 2023 classifications showed prognostic value, the new model improved risk stratification, clearly distinguishing high-risk groups. Multivariate analysis identified aggressive subtype, stage, age, diabetes, myometrial invasion and lymphovascular invasion as independent predictors.
Conclusions
Aggressive histological subtype in endometrial cancer should carry greater prognostic weight in terms of survival and clinical management. Our findings support a potential shift in the current paradigm for these relatively rare but high-risk cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, University Hospital of León, 24008 León, Spain.
- Department of Mathematics, University of León, 24008 León, Spain.
- Department of Gynecologic Oncology, Department of Obstetrics and Gynecology, Hospital Clínico San Carlos de Madrid, 28040 Madrid, Spain.
- Department of Gynecologic Oncology, Hospital Universitario Puerta de Hierro de Majadahonda, 28222 Madrid, Spain.
ORCID-Profile: Alicia Quirós, Pluvio Jesús Coronado Martín, Augusto Pereira Sánchez
Zitieren
APA
Cuesta-Guardiola, T., Quirós, A., Coronado Martín, P. J., & Pereira Sánchez, A. (2026). Improved Prognostic Staging in Endometrial Cancer: Clinical Impact of Aggressive Subtypes in a Multicenter Cohort. Medical Sciences, 14(3), 414. https://doi.org/10.3390/medsci14030414
Vancouver
Cuesta-Guardiola T, Quirós A, Coronado Martín PJ, Pereira Sánchez A. Improved Prognostic Staging in Endometrial Cancer: Clinical Impact of Aggressive Subtypes in a Multicenter Cohort. Medical Sciences. 2026;14(3):414. doi:10.3390/medsci14030414
BibTeX
@article{CuestaGuardiola2026,
author = {Cuesta-Guardiola, Tatiana and Quirós, Alicia and Coronado Martín, Pluvio Jesús and Pereira Sánchez, Augusto},
title = {Improved Prognostic Staging in Endometrial Cancer: Clinical Impact of Aggressive Subtypes in a Multicenter Cohort},
journal = {Medical Sciences},
year = {2026},
volume = {14},
number = {3},
pages = {414},
doi = {10.3390/medsci14030414}
}
EUVIMED